308 Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for melanoma

by Dirk Schadendorf, Mark Middleton, Jeffrey Weber, Delphine Hennicken, Paolo Ascierto, Andriy Moshyk, Roberto Zoffoli, Anne Pieters, Adenike Amadi, Katrin Kupas, Srividya Kotapati
Published 2020-11-01

Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)—estimation of adverse event risks

by Regina Stegherr, Claudia Schmoor, Jan Beyersmann, Kaspar Rufibach, Valentine Jehl, Andreas Brückner, Lewin Eisele, Thomas Künzel, Katrin Kupas, Frank Langer, Friedhelm Leverkus, Anja Loos, Christiane Norenberg, Florian Voss, Tim Friede
Published 2021-06-01